English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Purpose: To elucidate the diagnostic value of contrast enhanced mammography in comparison with dynamic MRI in cases of breast cancer recurrence and to correlate with available clinical data, histopathology findings and/or follow up. Methods: 30 patients were enrolled in this study. The age ranged between31-68 years old. Patients were referred from the General Surgery or Oncology Departments in the period from August-2015 until April-2018. The patients underwent full history taking and clinical examination and CESM and breast magnetic resonance image (BMRI) examination. Finally US guided biopsy was performed. Results: Contrast enhanced spectral mammography (CESM) showed slightly lower sensitivity (88.89%) and overall accuracy (86.67%) than BMRI (96.30% and 90% respectively). However specificity was higher in CESM (66.67%) than that of BMRI (33.33%). Conclusion: In spite of the lower sensitivity of the CESM compared to MRI, the CESM appeared to be a suitable, easy, more comfortable, low cost and fast alternative to MRI in early detection of breast cancer recurrence specially for patients with contraindications to MRI.

Comparison between the role of contrast enhanced mammography and dynamic contrast enhanced MRI in assessment of breast cancer recurrence